Atlanta, GA, United States of America

Erin Beth Dickerson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Georgia Tech Research Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erin Beth Dickerson. Retrieved from https://idiyas.com/inventor/erin-beth-dickerson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Erin Beth Dickerson: Innovator in Nanogel Technology

Introduction

Erin Beth Dickerson is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of nanotechnology, particularly in the development of nanogels for therapeutic applications. Her innovative work focuses on enhancing the delivery of therapeutics to target neoplastic conditions.

Latest Patents

Erin holds 1 patent for her invention titled "Nanogels for Cellular Delivery of Therapeutics." This patent encompasses various embodiments related to nanogels designed for the cellular delivery of therapeutics. The invention outlines systems and methods for targeted treatment of neoplastic conditions using nanogel-based technologies. A key feature of her delivery system includes a nanogel comprising a crosslinked polymer particle, with an active agent non-covalently associated within the nanogel.

Career Highlights

Erin is affiliated with the Georgia Tech Research Corporation, where she continues to advance her research in nanotechnology. Her work has garnered attention for its potential to revolutionize therapeutic delivery systems.

Collaborations

Erin collaborates with notable colleagues, including Louis Andrew Lyon and John Francis McDonald, contributing to a dynamic research environment focused on innovative solutions in healthcare.

Conclusion

Erin Beth Dickerson's contributions to nanogel technology exemplify the impact of innovative thinking in the field of therapeutics. Her work not only enhances the understanding of drug delivery systems but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…